Gene expression and function study of fusion immunotoxin anti-Her-2-scFv - SEC2 in Escherichia coli

Applied Microbiology and Biotechnology

Volumn 70, Issue 1, 2006, Pages 78-84

  Ming Kai, Xu ^a,b,c   Cheng Gang, Zhang ^a  

^a INSTITUTE OF APPLIED ECOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DNA; ENZYMES; ESCHERICHIA COLI; GENETIC ENGINEERING; IMMUNOLOGY; TUMORS;

BREAST TUMOR; FUSION IMMUNOTOXIN; GENE EXPRESSION; STAPHYLOCOCCUS AUREUS;

GENES;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOTOXIN;

GENE EXPRESSION;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENE FUSION; GENE OVEREXPRESSION; GENETIC LINKAGE; GENOMICS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; ENTEROTOXINS; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; IMMUNOTOXINS; MOLECULAR SEQUENCE DATA; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 32544449156     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-005-0049-z     Document Type: Article

References (22)

1. Altenschmidt U, Schmidt M, Groner B, Wels W (1997) Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin. Int J Cancer 73(1):117-124
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1995) Short protocols. In: Molecular biology, 3rd edn. Wiley, New York, p 39
3. Balaban N, Rasooly A (2000) Staphylococcal enterotoxins. Int J Food Microbiol 61:1-10
4. Baselga J, Mendelsohn J (1994) The epidermal-growth-factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 29:127-138
5. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091
6. Bohach GA, Schlievert PM (1987) Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol Gen Genet 209:15-20
7. Chen TZ (2001) Prog Microbiol Immunol China 29(2):63-69
8. Dohlsten M, Sundstedt A, Bjorklund M et al (1993) Superantigen-induced cytokines suppress growth of human colo-carcinoma cells. Int J Cancer 54:482-488
9. Hovde CJ, Hackett SP, Bohach GA (1990) Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins. Mol Gen Genet 220(2):329-333
10. Hynes NE, Stern DF (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165-184
11. Kalland T, Hedlund G, Dohlsten M, Lando PA (1991) Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. Curr Top Microbiol Immunol 174:81-92
12. Kreitman RJ (2003) Recombinant toxins for the treatment of cancer. Curr Opin Mol Ther 5(1):44-51
13. Lisan SP, Manuel LP, Sherie LM (1999) A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antibody activity. J Immunol 163 (1):250-258
14. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur J Immunol 21(8):1963-1966
15. Marshall KW, Marks JD (2001) Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of jurkat T cells. J Immunol 24(1):27-36
16. Pardoll DM (1995) Parakrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399-415
17. Passalacqua EF, Brehm RD, Acharya KR et al (1993) Crystallization and preliminary X-ray analysis of a microbial superantigen staphylococcal enterotoxin C2. J Mol Biol 233(1):170-172
18. Sambrook J, Fritsch EF, Maniatis T (2001) Molecular cloning, 3rd edn. Cold Spring Harbor Laboratory, New York, pp 27-30
19. HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2. Gynecol Oncol 80(2):145-155
20. Slamon DJ, Goldophin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A (1989) Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
21. Wahl C, Miethke T, Heeg K, Wagner H (1993) Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Eur J Immunol 23(5):1197-1200
22. Wang JZ, Fan M (2002) Manual of protein technology. Science, Beijing, China, pp 77-100